Compare IQIYI Inc - ADR (IQ) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IQIYI Inc - ADR vs Medpace Holdings Inc — how do they compare? IQIYI Inc - ADR trades at $1.26 (market cap $1.20B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: Medpace Holdings Inc is far larger — about 12.6× IQIYI Inc - ADR's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals.
| IQ | MEDP | |
|---|---|---|
Market Cap | $1.20B | $15.08B |
Sector | Media | Technology |
52-Week High | $2.79 | $620.59 |
52-Week Low | $0.96 | $308.88 |
Enterprise Value | $2.76B | $14.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
